Rare diseases
Investigational molecules
Locations
Auf Den Lueppen 10, Hoerbach, 35745, Germany
Research activity is centred on irritable bowel syndrome, with particular attention to the diarrhoea-predominant form (IBS-D) and its burden of persistent gastrointestinal symptoms.
The sponsor’s clinical interest in this area is focused on oral treatment approaches for patients with functional bowel disorders.
SymbioPharm GmbH runs clinical trials in conditions such as Irritable bowel syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
